GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicofarma Biotech SA (WAR:MDB) » Definitions » Shiller PE Ratio

Medicofarma Biotech (WAR:MDB) Shiller PE Ratio : (As of May. 30, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Medicofarma Biotech Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Medicofarma Biotech Shiller PE Ratio Historical Data

The historical data trend for Medicofarma Biotech's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicofarma Biotech Shiller PE Ratio Chart

Medicofarma Biotech Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Medicofarma Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Medicofarma Biotech's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Medicofarma Biotech's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicofarma Biotech's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicofarma Biotech's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medicofarma Biotech's Shiller PE Ratio falls into.



Medicofarma Biotech Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medicofarma Biotech's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Medicofarma Biotech's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0/149.0435*149.0435
=0.000

Current CPI (Mar. 2024) = 149.0435.

Medicofarma Biotech Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201403 -0.006 101.262 -0.009
201406 -0.009 101.180 -0.013
201409 -0.008 100.611 -0.012
201412 0.009 100.122 0.013
201503 -0.007 100.041 -0.010
201506 -0.003 100.448 -0.004
201509 -0.002 99.634 -0.003
201512 0.001 99.471 0.001
201603 -0.007 98.983 -0.011
201606 -0.008 99.552 -0.012
201609 -0.001 99.064 -0.002
201612 0.020 100.366 0.030
201703 -0.007 101.018 -0.010
201706 -0.006 101.180 -0.009
201709 0.002 101.343 0.003
201712 0.019 102.564 0.028
201803 -0.005 102.564 -0.007
201806 -0.004 103.378 -0.006
201809 0.001 103.378 0.001
201812 0.016 103.785 0.023
201903 -0.011 104.274 -0.016
201906 -0.013 105.983 -0.018
201909 -0.017 105.983 -0.024
201912 -0.010 107.123 -0.014
202003 -0.020 109.076 -0.027
202006 -0.013 109.402 -0.018
202009 -0.012 109.320 -0.016
202012 -0.090 109.565 -0.122
202103 0.016 112.658 0.021
202106 0.004 113.960 0.005
202109 0.000 115.588 0.000
202112 -0.009 119.088 -0.011
202203 -0.003 125.031 -0.004
202206 -0.009 131.705 -0.010
202209 -0.007 135.531 -0.008
202212 -0.005 139.113 -0.005
202303 -0.009 145.950 -0.009
202306 -0.009 147.009 -0.009
202309 -0.007 146.113 -0.007
202403 0.000 149.044 0.000

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Medicofarma Biotech  (WAR:MDB) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Medicofarma Biotech Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Medicofarma Biotech's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicofarma Biotech (WAR:MDB) Business Description

Traded in Other Exchanges
N/A
Address
ul. Soko?owska 9 lok. U19, Warsaw, POL, 01-142
Medicofarma Biotech SA operates in the pharmaceutical industry. The company specializes in contract manufacturing of medical devices, medicinal products and dietary supplements. The business is spread across Austria, Czech Republic, Spain, Ireland, Canada, Germany, Norway, Sweden, Great Britain, and Italy.